首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1485800

神经生物标记市场的免疫测定，按疾病类型、副产品、最终用户、技术、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Immunoassay for Neurological Biomarkers Market, By Disease Type, By Product, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年05月13日 | 出版商:

AnalystView Market Insights | 英文 397 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2023 年神经生物标记免疫测定市场规模为 7.0767 亿美元，2024 年至 2032 年复合年增长率为 17.5%。

神经生物标记市场的免疫分析-市场动态

神经和精神疾病病例不断增加

神经生物标记免疫分析市场在神经和精神疾病的检测和诊断中发挥重要作用。免疫测定可以及早检测与阿兹海默症、帕金森氏症、多发性硬化症等各种疾病相关的神经生物标记。早期检测有助于早期介入和治疗，有可能减缓疾病进展并改善患者预后。据世界卫生组织 (WHO) 称，全球有超过 30 亿人因疾病和残疾而患有神经系统疾病。此外，超过 80% 的神经系统死亡发生在低收入和中等收入国家。

神经生物标记市场的免疫测定 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 17.5% 左右的复合年增长率成长

根据疾病类型细分，阿兹海默症预计将在 2023 年占据最大市场份额

从技术细分来看，放射免疫分析（RIA）是2023年的主导类型

根据最终用户细分，2023年医院是领先类型

按地区划分，北美是 2023 年的主要收入来源

神经生物标记免疫测定市场細項分析：

全球神经生物标记免疫测定市场根据疾病类型、产品、最终用户、技术和地区进行细分。

根据疾病类型，市场分为六类：生物标记免疫测定可以在临床症状出现之前及早发现 AD。免疫测定广泛用于旨在开发 AD 新疗法的临床试验。它们帮助研究人员衡量实验治疗对生物标记水平的影响，并评估其潜在功效和安全性。

根据最终用户，市场分为六类：神经生物标记的免疫测定广泛用于医院，用于与神经系统疾病的诊断、预后和监测相关的各种目的。例如，某些生物标记的水平可能表明疾病的严重程度或进展，帮助临床医生预测疾病可能的病程并规划适当的治疗策略。

神经生物标记市场的免疫测定 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

就免疫分析神经生物标记市场的收入而言，北美拥有全球最大的市场份额。这是由于更好的政府措施和强劲的经济。由于分子诊断的使用不断增加，美国是该市场的领导者。在欧洲，由于竞争加剧和人们意识的提高，市场正在成长。利害关係人对涉及蛋白质、相关生物分子和基因的研究项目的关注是推动欧洲神经免疫分析市场成长的关键因素。

神经生物标记免疫分析市场-竞争格局：

由于市场参与者采取的各种策略性倡议，用于神经生物标记的免疫测定市场正在迅速扩大。这些措施包括开发用于诊断和治疗研究的先进生物标记技术。例如，2022 年12 月，美国FDA 批准了F. Hoffmann-La Roche Ltd 开发的两种免疫测定法。 42) CSF II （Abeta42）。这些测定可用于测量成年患者的两种重要生物标记：tau 蛋白和 β-淀粉样蛋白。它们有助于确认阿兹海默症的诊断。

市场片段
- 神经生物标记免疫测定市场片段（依疾病类型）
- 神经生物标记免疫测定市场片段（按产品）
- 最终用户的神经生物标记免疫测定市场片段
- 神经生物标记免疫分析市场片段（依技术）
- 神经生物标记免疫测定市场片段（按国家/地区）
- 神经生物标记免疫测定市场片段（按地区）
竞争洞察

第 3 章：神经生物标记的免疫测定主要市场趋势

神经生物标记市场驱动因素的免疫测定
- 市场驱动因素的影响分析
神经生物标记市场限制的免疫分析
- 市场限制影响分析
神经生物标记免疫分析市场机会
神经生物标记免疫分析市场未来趋势

第 4 章：神经生物标记免疫测定产业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：神经生物标记市场的免疫测定：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：神经生物标记免疫测定市场格局

神经生物标记免疫分析市占率分析，2023 年
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：神经生物标记市场的免疫分析 - 按疾病类型

概述
- 按疾病类型分類的细分市场份额分析
- 阿兹海默氏症
- 帕金森氏症
- 亨丁顿舞蹈症
- 肌萎缩侧索硬化症 (ALS)
- 脊髓性肌肉萎缩症 (SMA)
- 其他的

第 8 章：神经生物标记市场的免疫分析 - 副产品

概述
- 按产品分類的细分市场占有率分析
- 仪器
- 试剂
- 服务

第 9 章：神经生物标记市场的免疫分析 - 由最终用户

概述
- 按最终用户分類的细分市场占有率分析
- 医院
- 诊所
- 学术组织
- 生物製药公司
- 製药公司
- 其他的

第 10 章：神经生物标记市场的免疫分析 - 按技术

概述
- 按技术分類的细分市场份额分析
- 放射免疫分析 (RIA)
- 聚合酶炼式反应 (PCR)
- 酵素连结免疫吸附试验
- 蛋白质印迹
- 快速测试
- 酵素连结免疫斑点法

第 11 章：神经生物标记市场的免疫分析 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 神经生物标记免疫测定北美主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按疾病类型）
- 北美市场规模和预测（按产品）
- 北美市场规模和预测（按最终用户）
- 北美市场规模和预测（按技术）
- 我们
- 加拿大
欧洲
- 概述
- 神经生物标记免疫测定欧洲主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按疾病类型）
- 欧洲市场规模和预测（按产品）
- 欧洲市场规模和预测（按最终用户）
- 欧洲市场规模与预测（按技术）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 神经生物标记免疫测定亚太地区主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按疾病类型）
- 亚太地区市场规模与预测（按产品）
- 亚太地区市场规模和预测（按最终用户）
- 亚太地区市场规模与预测（按技术）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 神经生物标誌物免疫测定拉丁美洲主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按疾病类型）
- 拉丁美洲市场规模与预测（按产品）
- 拉丁美洲市场规模和预测（按最终用户）
- 拉丁美洲市场规模与预测（按技术）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 神经生物标记免疫测定中东和非洲主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按疾病类型）
- 中东和非洲市场规模及预测（按产品）
- 中东和非洲市场规模及预测（按最终用户）
- 中东和非洲市场规模及预测（按技术）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 12 章：主要供应商分析 - 神经生物标记产业的免疫测定

竞争仪表板
公司简介
- QIAGEN
- Abbott
- Merck & Co., Inc.
- Johnson & Johnson Services, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Merck KGaA
- F. Hoffmann La-Roche Ltd.
- Nimble Therapeutics
- ADx NeuroSciences NV
- Enrolmmun
- ACOBIOM
- Banyan Biomarkers Inc.
- Olink Biosciences
- Others

第 13 章：360 度分析师视角

第 14 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV2703

REPORT HIGHLIGHT

Immunoassay for Neurological Biomarkers Market size was valued at USD 707.67 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.

Immunoassays for neurological biomarkers are laboratory techniques used to measure the levels of certain molecules in biological samples, such as blood or cerebrospinal fluid, that are indicative of neurological conditions or diseases. The rising prevalence of neurological disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis creates a growing need for reliable biomarkers for early diagnosis, prognosis, and monitoring of disease progression. However, the market is facing some regulatory approval for new biomarkers and immunoassays which can be a lengthy and costly process, hindering the translation of research findings into clinically useful diagnostics. Furthermore, there is a growing emphasis on the development of biomarkers for early diagnosis and monitoring of neurological diseases, creating opportunities in future.

Immunoassay for Neurological Biomarkers Market- Market Dynamics

Rising cases of neurological and psychiatric disorders

The Immunoassay for Neurological Biomarkers market plays a significant role in the detection and diagnosis of neurological and psychiatric disorders. Immunoassays allow for the early detection of neurological biomarkers associated with various disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Early detection enables early intervention and treatment, potentially slowing down disease progression and improving patient outcomes. According to the World Health Organization (WHO), more than 3 billion people worldwide are living with a neurological condition due to illness & disability. In addition, over 80% of neurological deaths occur in low- and middle-income countries.

Immunoassay for Neurological Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)

Based on disease type segmentation, Alzheimer's disease was predicted to show maximum market share in the year 2023

Based on technology segmentation, radioimmunoassays (RIA) was the leading type in 2023

Based on end user segmentation, hospitals were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:

The Global Immunoassay for Neurological Biomarkers Market is segmented based on Disease Type, Product, End User, Technology, and Region.

The market is divided into six categories based on disease type: Biomarker immunoassays enable early detection of AD even before clinical symptoms appear. Immunoassays are widely used in clinical trials aimed at developing new therapies for AD. They help researchers measure the impact of experimental treatments on biomarker levels and assess their potential efficacy and safety.

The market is divided into six categories based on end user: Immunoassays for neurological biomarkers are widely used in hospitals for various purposes related to the diagnosis, prognosis, and monitoring of neurological disorders. For instance, levels of certain biomarkers might indicate the severity or progression of a disease, helping clinicians predict the likely course of the illness and plan appropriate treatment strategies.

Immunoassay for Neurological Biomarkers Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America has the largest market share in terms of revenue across the world for the immunoassay neurological biomarkers market. This is due to better government initiatives and a strong economy. The United States is a leader in this market, driven by the increasing use of molecular diagnosis. In Europe, the market is growing due to rising competition and increased awareness among the population. The stakeholders' focus on research projects involving proteins, associated biomolecules, and genes are the key factors driving the growth of the neuro immunoassay market in Europe.

Immunoassay for Neurological Biomarkers Market- Competitive Landscape:

The market for immunoassays used for neurological biomarkers is expanding rapidly due to various strategic initiatives taken by market players. These initiatives include the development of advanced biomarker technology for diagnostic and treatment research. For instance, in December 2022, the United States FDA approved two immunoassays developed by F. Hoffmann-La Roche Ltd. These immunoassays are Elecsys Phospho-Tau (181P) CSF (pTau181) and Elecsys beta-Amyloid (1-42) CSF II (Abeta42). These assays are useful for measuring two important biomarkers, tau proteins, and beta-amyloid, in adult patients. They aid in the confirmation of Alzheimer's disease diagnosis.

Recent Developments:

In February 2024, Abbott and Fujirebio announced partnering to develop a research-use-only test for the neurofilament-light chain (NfL). The neurology biomarker assay will be available for use on Abbott's Alinity I instrument and also will be offered to researchers conducting studies demonstrating the utility of the NfL biomarker.

In March 2023, H.U. Group Holdings Inc. and its subsidiary, Fujirebio, announced the release of two new assays, Lumipulse G NfL CSF and Lumipulse G NfL Blood, for LUMIPULSE G immunoassay systems. These CLEIA assays enable the accurate measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Abbott

Merck & Co., Inc.

Johnson & Johnson Services, Inc.

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Sysmex Corporation

Merck KGaA

F. Hoffmann La-Roche Ltd.

Nimble Therapeutics

ADx NeuroSciences NV

Enrolmmun

ACOBIOM

Banyan Biomarkers Inc.

Olink Biosciences

Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

Alzheimer's Disease
Parkinson's Disease
Huntington's Disease
Amyotrophic Lateral Sclerosis (ALS)
Spinal Muscular Atrophy (SMA)
Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Instruments
Reagents
Services

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Clinics
Academic Organizations
Biopharmaceutical Companies
Pharmaceutical Companies
Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Radioimmunoassays (RIA)
Polymerase Chain Reaction (PCR)
ELISA
Western Blot
Rapid Tests
ELISPOT

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Immunoassay For Neurological Biomarkers Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Immunoassay For Neurological Biomarkers Market Snippet by Disease Type
- 2.1.2.Immunoassay For Neurological Biomarkers Market Snippet by Product
- 2.1.3.Immunoassay For Neurological Biomarkers Market Snippet by End User
- 2.1.4.Immunoassay For Neurological Biomarkers Market Snippet by Technology
- 2.1.5.Immunoassay For Neurological Biomarkers Market Snippet by Country
- 2.1.6.Immunoassay For Neurological Biomarkers Market Snippet by Region
2.2.Competitive Insights

3.Immunoassay For Neurological Biomarkers Key Market Trends

3.1.Immunoassay For Neurological Biomarkers Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Immunoassay For Neurological Biomarkers Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Immunoassay For Neurological Biomarkers Market Opportunities
3.4.Immunoassay For Neurological Biomarkers Market Future Trends

4.Immunoassay For Neurological Biomarkers Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Immunoassay For Neurological Biomarkers Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Immunoassay For Neurological Biomarkers Market Landscape

6.1.Immunoassay For Neurological Biomarkers Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Immunoassay For Neurological Biomarkers Market - By Disease Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 7.1.2.Alzheimer's Disease
- 7.1.3.Parkinson's Disease
- 7.1.4.Huntington's Disease
- 7.1.5.Amyotrophic Lateral Sclerosis (ALS)
- 7.1.6.Spinal Muscular Atrophy (SMA)
- 7.1.7.Others

8.Immunoassay For Neurological Biomarkers Market - By Product

8.1.Overview
- 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
- 8.1.2.Instruments
- 8.1.3.Reagents
- 8.1.4.Services

9.Immunoassay For Neurological Biomarkers Market - By End User

9.1.Overview
- 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2.Hospitals
- 9.1.3.Clinics
- 9.1.4.Academic Organizations
- 9.1.5.Biopharmaceutical Companies
- 9.1.6.Pharmaceutical Companies
- 9.1.7.Others

10.Immunoassay For Neurological Biomarkers Market - By Technology

10.1.Overview
- 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 10.1.2.Radioimmunoassays (RIA)
- 10.1.3.Polymerase Chain Reaction (PCR)
- 10.1.4.ELISA
- 10.1.5.Western Blot
- 10.1.6.Rapid Tests
- 10.1.7.ELISPOT

11.Immunoassay For Neurological Biomarkers Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Immunoassay For Neurological Biomarkers Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Immunoassay For Neurological Biomarkers Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.QIAGEN
- 12.2.2.Abbott
- 12.2.3.Merck & Co., Inc.
- 12.2.4.Johnson & Johnson Services, Inc.
- 12.2.5.Thermo Fisher Scientific, Inc.
- 12.2.6.Bio-Rad Laboratories, Inc.
- 12.2.7.Sysmex Corporation
- 12.2.8.Merck KGaA
- 12.2.9.F. Hoffmann La-Roche Ltd.
- 12.2.10.Nimble Therapeutics
- 12.2.11.ADx NeuroSciences NV
- 12.2.12.Enrolmmun
- 12.2.13.ACOBIOM
- 12.2.14.Banyan Biomarkers Inc.
- 12.2.15.Olink Biosciences
- 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Immunoassay For Neurological Biomarkers Market: Disease Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease Type
TABLE Global Immunoassay For Neurological Biomarkers Market, by Disease Type 2019-2032 (USD Million)
TABLE Immunoassay For Neurological Biomarkers Market: Product Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Product
TABLE Global Immunoassay For Neurological Biomarkers Market, by Product 2019-2032 (USD Million)
TABLE Immunoassay For Neurological Biomarkers Market: End User Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by End User
TABLE Global Immunoassay For Neurological Biomarkers Market, by End User 2019-2032 (USD Million)
TABLE Immunoassay For Neurological Biomarkers Market: Technology Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Immunoassay For Neurological Biomarkers Market, by Technology 2019-2032 (USD Million)
TABLE Immunoassay For Neurological Biomarkers Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Immunoassay For Neurological Biomarkers Market, by Region 2019-2032 (USD Million)
TABLE North America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE North America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
TABLE North America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
TABLE North America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
TABLE North America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
TABLE Europe Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Europe Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
TABLE Europe Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
TABLE Europe Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
TABLE Europe Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
TABLE Latin America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)